Total planned funding: $828,245,978
Clear active filters
HTXD: Treatment: ARV Drugs
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
| Nigeria | $187,276,663 |
| Kenya | $174,740,186 |
| Uganda | $109,340,623 |
| Zambia | $84,497,597 |
| Tanzania | $55,143,117 |
| Mozambique | $41,557,096 |
| Côte d'Ivoire | $31,828,078 |
| South Africa | $29,562,772 |
| Zimbabwe | $27,596,822 |
| Rwanda | $22,022,946 |
| Haiti | $17,388,276 |
| Eswatini | $7,701,201 |
| Botswana | $7,572,550 |
| Vietnam | $7,293,925 |
| Ethiopia | $7,005,345 |
| Malawi | $6,892,489 |
| Democratic Republic of the Congo | $5,745,595 |
| Namibia | $1,879,596 |
| South Sudan | $1,214,992 |
| Guyana | $1,013,698 |
| Burundi | $972,411 |
Organizational Types
| Private Contractor | $610,928,742 |
| Host Country Government Agency | $98,531,756 |
| NGO | $57,755,340 |
| Unknown | $22,768,996 |
| FBO | $16,091,491 |
| Implementing Agency | $14,376,825 |
| University | $4,124,263 |
| Own Agency | $2,594,939 |
| Parastatal | $1,073,626 |
| Other USG Agency | $0 |
Program Areas
| Treatment | $828,245,978 |
Budget Codes
| HTXD: Treatment: ARV Drugs | $828,245,978 |